PC - B97&A93 - What's New in Clinical and Translational Research in Pulmonary Hypertension: Lessons from the Best Abstracts
Date: Wednesday, October 21, 2020
<Back to Mini Symposia Main Page
Moderated By: Olivier Boucherat, PhD, Harm Bogaard, MD, PhD and Corey Ventetuolo, MD, MSc
- Angiopoietin Associations Across the Cardiovascular Disease Spectrum: The Mesa Angiogenesis Study – Brandon Peplinski, MD, MPH (1:08)
- Application of Machine Learning in Pulmonary Arterial Hypertension Risk Stratification – Raymond Benza, MD (12:34)
- Radiographic Pulmonary Vascular Pruning and Right Ventricular Function in the Framingham Heart Study – Andrew Synn, MD (29:29)
- Increased Risk of Death in Underweight and Normal Weight Patients with Pulmonary Hypertension – Aaron Trammell, MD, MSc (40:38)
- 2019 Updated Consensus Statement on the Diagnosis and Treatment of Pediatric Pulmonary Hypertension: The European Pediatric Pulmonary Vascular Disease Network (EPPVDN), Endorsed by AEPC, ESPR and ISHLT - Eric Austin MD, MSc (53:19)
- PVDOMICS: Early Metabolic Findings Across the Spectrum of Pulmonary Hypertension – Anna Hemnes, MD (1:06:29)
- United States CTEPH Registry: Differences Between Operated and Non-Operated Subjects in Baseline Data and 1-Year Outcomes – Kim Kerr, MD (1:21:24)
- The NFU1 G206C Mutation Metabolically Reprograms Pulmonary Artery Smooth Muscle Cells, Promotes Proliferation and Apoptosis Resistance – Joel James, PhD (1:31:40)
